Therapeutic proteins immunogenicity: a peptide point of view
Protein therapeutics are extensively used in the treatment of autoimmune diseases, but a subset of patients appears to be refractory to these treatments, mainly due to the development of an immune response to the drug. A better understanding of the mechanism underlying the therapeutic drug’s failure...
Saved in:
Main Authors: | Feliciana Real-Fernandez, Fosca Errante, Andrea Di Santo, Anna Maria Papini, Paolo Rovero |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration
2023-10-01
|
Series: | Exploration of Drug Science |
Subjects: | |
Online Access: | https://www.explorationpub.com/uploads/Article/A100825/100825.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
T and B cell epitope analysis for the immunogenicity evaluation and mitigation of antibody-based therapeutics
by: Ruoxuan Sun, et al.
Published: (2024-12-01) -
Structural information in therapeutic peptides: Emerging applications in biomedicine
by: Valentín Iglesias, et al.
Published: (2025-02-01) -
Cytological evaluation by Caco-2 and KU812 of non-allergenic peptides from simulated digestion of infant formula in vitro
by: Zihao Xu, et al.
Published: (2023-05-01) -
Synthetic peptides as valuable and versatile tools for research: our 20 year journey in Chile
by: Constanza Cárdenas, et al.
Published: (2024-10-01) -
Peptide Aptamer–Paclitaxel Conjugates for Tumor Targeted Therapy
by: Xinyang Shen, et al.
Published: (2024-12-01)